Mainz Biomed (MYNZ) supports Colorectal Cancer Awareness Month in March. Detecting colorectal cancer in its early stages significantly improves ...

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention ...

Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the ...

Partnership to Launch DNA-Based Colorectal Cancer Screening TestBERKELEY, Calif. and MAINZ, Germany, Feb. 20, 2025 (GLOBE ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...

MYNZ stock opened at $6.04 on Friday. Mainz Biomed has a one year low of $3.65 and a one year high of $45.60. The company’s fifty day moving average price is $5.32 and its 200-day moving average ...

Analyst Price Forecast Suggests 66.00% Downside As of November 21, 2024, the average one-year price target for Mainz Biomed N.V. is $2.04/share. The forecasts range from a low of $2.02 to a high ...

Vilin Bio Med - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent VILIN BIO MED LIMITED has informed the Exchange about Change in Directors/ Key ...

We recently (September 2025) stayed at the Club Med (Playa Del Carmen) Punta Cana. The Club Med in Punta Cana had experienced a fire so were moved up the coast the their other resort. The resort ...

Mainz Biomed N.V. (MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to share that its ...